• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

    93.48 -2.53 (-2.64%)
    Streaming Delayed Price Updated: 1:22 PM EST, Jan 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about GeneDx Holdings Corp. - Class A Common Stock

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    News headline image
    GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million ↗
    GeneDx (NASDAQ: WSG) to acquire Fabric Genomics, pioneer in AI-powered genomic interpretation, for up to $51 million. Expanding global reach and improving precision diagnostics. 
    Via Benzinga
    News headline image
    IBD 50's GeneDx Inks $84 Million AI-Tied Takeover Deal ↗
    GeneDx will pay up to $84 million to acquire Fabric Genomics for its AI-powered genomics interpretation platform. 
    Via Investor's Business Daily
    Topics Artificial Intelligence
    News headline image
    GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
    From GeneDx
    Via Business Wire
    News headline image
    Why GENEDX HOLDINGS CORP (NASDAQ:WGS) could fit Mark Minervini’s high-growth criteria ↗
    A fundamental and technical analysis of (NASDAQ:WGS): Should you consider GENEDX HOLDINGS CORP (NASDAQ:WGS) for high growth investing? 
    Via Chartmill
    News headline image
    GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From GeneDx
    Via Business Wire
    News headline image
    Unlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS). ↗
    Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS). A fundamental and technical analysis of (NASDAQ:WGS). 
    Via Chartmill
    News headline image
    Does GENEDX HOLDINGS CORP (NASDAQ:WGS) align with Mark Minervini’s trading strategy? ↗
    A fundamental and technical analysis of (NASDAQ:WGS): Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS). 
    Via Chartmill
    News headline image
    Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
    From GeneDx
    Via Business Wire
    News headline image
    SPY Trying To Find A Floor At The 200 SMA; One New Swing ↗
    In this video lesson I review the day-one of a new rally attempt in the overall market, discuss my new swing trade in a cyber-security leader, and review my tier-one long-term portfolio purchases in my... 
    Via Talk Markets
    Topics Stocks / Equities
    News headline image
    GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
    From GeneDx
    Via Business Wire
    News headline image
    Powerful UnR Session As All Four Market Indices Lockstep Rally Into The Close; Bear Trap Set? ↗
    In this video lesson, I review the overall market, the recent bearish sentiment, and one new swing trade idea for Monday's session. 
    Via Talk Markets
    Topics Stocks / Equities
    News headline image
    Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols
    From GeneDx
    Via Business Wire
    News headline image
    Top Biotech GeneDx Catapults 42% After Obliterating Earnings Forecasts ↗
    GeneDx stock catapulted more than 40% on Tuesday after the top-notch biotech smashed fourth-quarter expectations. 
    Via Investor's Business Daily
    News headline image
    Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings ↗
     
    Via Benzinga
    News headline image
    Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday ↗
     
    Via Benzinga
    News headline image
    US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday? ↗
    Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday. 
    Via Benzinga
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025
    From GeneDx
    Via Business Wire
    News headline image
    WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? ↗
    Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%), SOC (+39.09%), WGS (+28.23%), VNET (+28.22%), NSP (+25.99%), CRSP (+25.21%), AXSM (+24.01%) 
    Via Benzinga
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
     
    Via Benzinga
    News headline image
    GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
    From GeneDx
    Via Business Wire
    News headline image
    Earnings Scheduled For February 18, 2025 ↗
     
    Via Benzinga
    News headline image
    GeneDx to Participate in 45th Annual TD Cowen Health Care Conference
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025
    From GeneDx
    Via Business Wire
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.